Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2020		272,154,504
Beginning balance at Dec. 31, 2020	$ 341,599	$ 2,722	$ 741,113	$ (26,233)	$ (376,003)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	93,192				93,192
Other comprehensive (loss) income	(65,541)			(65,541)
Acquisition option exercises, net (in shares)		3,141,342
Acquisition option exercises, net	182,390	$ 31	182,359
Purchase of capped call options, net of tax of $12,871	(38,734)		(38,734)
Dividends declared	(33,537)				(33,537)
Shares issued in connection with DCP, net (in shares)		2,378,645
Shares issued in connection with DCP, net	(69,007)	$ 24			(69,031)
DCP elective participant deferrals	2,619		2,619
DCP modification	(4,739)		(4,739)
Shares issued in connection with Executive Bonus Plan, net (in shares)		238,755
Shares issued in connection with Bonus Plan, net	12,214	$ 2	20,951		(8,739)
Shares issued in connection with employee stock purchase plan (in shares)		104,716
Shares issued and repurchased in connection with employee stock purchase plan, net	3,408	$ 1	3,845		(438)
Stock option exercises, net (in shares)		4,587,053
Stock option exercises, net	(32,180)	$ 46	5,559		(37,785)
Shares issued for stock grants, net (in shares)		7,824
Shares issued for stock grants, net	450		450
Stock-based compensation expense	24,382		24,382
Shares related to restricted stock, net (in shares)		(86,120)
Shares related to restricted stock, net	(7,294)	$ (1)			(7,293)
Ending balance (in shares) at Dec. 31, 2021		282,526,719
Ending balance at Dec. 31, 2021	409,222	$ 2,825	937,805	(91,774)	(439,634)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	174,780				174,780
Other comprehensive (loss) income	2,034			2,034
Acquisition option exercises, net (in shares)		185,178
Acquisition option exercises, net	0	$ 2	(2)
Dividends declared	(34,353)				(34,353)
Shares issued in connection with DCP, net (in shares)		3,541,375
Shares issued in connection with DCP, net	(24,246)	$ 35	(27)		(24,254)
DCP elective participant deferrals	6,580		6,580
Shares issued in connection with Executive Bonus Plan, net (in shares)		445,050
Shares issued in connection with Bonus Plan, net	16,728	$ 5	21,920		(5,197)
Shares issued in connection with employee stock purchase plan (in shares)		307,406
Shares issued and repurchased in connection with employee stock purchase plan, net	$ 10,062	$ 3	10,332		(273)
Stock option exercises, net (in shares)	900,000	2,613,659
Stock option exercises, net	$ (850)	$ 26	8,312		(9,188)
Shares issued for stock grants, net (in shares)		13,632
Shares issued for stock grants, net	450		450
Stock-based compensation expense	45,100		45,100
Shares related to restricted stock, net (in shares)		277,594
Shares related to restricted stock, net	(4,492)	$ 3	(4)		(4,491)
Repurchase of Class B Common Stock under approved program (in shares)		(896,126)
Repurchases of Class B common stock under approved program	(28,250)	$ (9)			(28,241)
Other	(15)				(15)
Non-controlling interest acquired	704					704
Ending balance (in shares) at Dec. 31, 2022		289,014,487
Ending balance at Dec. 31, 2022	573,454	$ 2,890	1,030,466	(89,740)	(370,866)	704
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	326,787				326,787
Other comprehensive (loss) income	4,753			4,753
Dividends declared	(58,756)				(58,756)
Shares issued in connection with DCP, net (in shares)		3,410,006
Shares issued in connection with DCP, net	(38,456)	$ 34	(34)		(38,456)
DCP elective participant deferrals	1,765		1,765
Shares issued in connection with Executive Bonus Plan, net (in shares)		247,867
Shares issued in connection with Bonus Plan, net	11,035	$ 3	16,788		(5,756)
Shares issued in connection with employee stock purchase plan (in shares)		315,840
Shares issued and repurchased in connection with employee stock purchase plan, net	9,143	$ 3	9,985		(845)
Stock option exercises, net (in shares)		2,621,959
Stock option exercises, net	5,134	$ 26	11,689		(6,581)
Shares issued for stock grants, net (in shares)		12,639
Shares issued for stock grants, net	600		600
Stock-based compensation expense	55,982		55,982
Shares related to restricted stock, net (in shares)		643,039
Shares related to restricted stock, net	(7,299)	$ 7	(7)		(7,299)
Other	(160)				(160)
Ending balance (in shares) at Dec. 31, 2023		296,265,837
Ending balance at Dec. 31, 2023	$ 883,982	$ 2,963	$ 1,127,234	$ (84,987)	$ (161,932)	$ 704